Duke Investigational Chemotherapy Services — Durham, North Carolina

Duke Investigational Chemotherapy Services is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Investigational Chemotherapy Services has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Investigational Chemotherapy Services?

Duke Investigational Chemotherapy Services has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Investigational Chemotherapy Services conducted?

Duke Investigational Chemotherapy Services has 1 clinical trials on record, with 1 currently active. Their work covers Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate.

Is Duke Investigational Chemotherapy Services accredited by Crixeo Health?

Duke Investigational Chemotherapy Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Investigational Chemotherapy Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.